153 related articles for article (PubMed ID: 14312774)
1. THE RATE OF RECOVERY OF REVERSIBLE MYOPATHIES AND THE EFFECTS OF ANABOLIC AGENTS IN STEROID MYOPATHY.
COOMES EN
Neurology; 1965 Jun; 15():523-30. PubMed ID: 14312774
[No Abstract] [Full Text] [Related]
2. THE COMBINATION OF ANABOLIC STEROIDS AND CORTICOSTEROIDS IN THE TREATMENT OF RHEUMATOID ARTHRITIS.
BEATTY DC; MASHETER HC
Proc R Soc Med; 1964 Aug; 57(8):671-2. PubMed ID: 14195852
[No Abstract] [Full Text] [Related]
3. [CLINICAL STUDIES ON THE PHYSIOLOGY AND THE PATHOLOGY OF HORMONES].
MIYAKE T
Nihon Ishikai Zasshi; 1964 Jan; 51():7-25. PubMed ID: 14118055
[No Abstract] [Full Text] [Related]
4. [ANABOLIC STEROIDS AND THEIR HORMONAL SIDE EFFECTS].
SCHINDLER H; KORN A
Munch Med Wochenschr; 1965 Mar; 107():479-85. PubMed ID: 14266624
[No Abstract] [Full Text] [Related]
5. METHANDROSTENOLONE, AN ORAL ANABOLIC AGENT.
JUNGCK EC; GREENBLATT RB
South Med J; 1964 Aug; 57():909-13. PubMed ID: 14173048
[No Abstract] [Full Text] [Related]
6. Reversible myopathies--their rate of recovery and the effect of anabolic agents.
Coomes EN
Ann Phys Med; 1965 Nov; 8(4):113-9. PubMed ID: 5857027
[No Abstract] [Full Text] [Related]
7. [ADVANTAGES AND HAZARDS OF ANABOLIC AGENTS].
SCHULZE G
Therapiewoche; 1964 Apr; 14():426-32. PubMed ID: 14147411
[No Abstract] [Full Text] [Related]
8. CORTICOSTEROID OSTEOPOROSIS AND TREATMENT WITH ANABOLIC HORMONE.
LUND H
Acta Med Scand; 1963 Dec; 174():735-8. PubMed ID: 14089264
[No Abstract] [Full Text] [Related]
9. CLINICAL ASPECTS OF ADRENAL CORTICAL FUNCTION WITH SPECIAL EMPHASIS ON CUSHING'S SYNDROME.
WINTERNITZ WW
J Ky Med Assoc; 1963 Oct; 61():862-8. PubMed ID: 14051887
[No Abstract] [Full Text] [Related]
10. [CUSHING'S SYNDROME IN A RHEUMATOID ARTHRITIS PATIENT FOLLOWING PROLONGED CORTICOTHERAPY].
OBRADOV S; DJUGUMOVIC Z; TOMIC S; SELAK I; CUSTOVIC K
Med Glas; 1964 Nov; 18():364-6. PubMed ID: 14312675
[No Abstract] [Full Text] [Related]
11. [STUDIES ON DRUG DIABETES. 3. ABNORMAL CARBOHYDRATE METABOLISM CAUSED BY ANABOLIC STEROIDS].
ISHIGAMI R; SHIOTANI S; YOSHIDA A; KAWATA T; NATORI H; AKIYAMA Y; OHMOTO J; OKADA H; SHIMO C
Naika Hokan; 1964 Aug; 11():359-66. PubMed ID: 14214527
[No Abstract] [Full Text] [Related]
12. Steroid myopathy.
Yates DA
Rheumatol Phys Med; 1971 Feb; 11(1):28-33. PubMed ID: 5551093
[No Abstract] [Full Text] [Related]
13. [CLINICAL STUDIES ON THE EFFECT OF A NEW ANABOLIC STEROID].
WELLER O
Med Welt; 1964 Apr; 14():782-9. PubMed ID: 14198051
[No Abstract] [Full Text] [Related]
14. NATURAL HISTORY OF PITUITARY-ADRENAL RECOVERY FOLLOWING LONG-TERM SUPPRESSION WITH CORTICOSTEROIDS.
GRABER AL; NEY RL; NICHOLSON WE; ISLAND DP; LIDDLE GW
Trans Assoc Am Physicians; 1964; 77():296-306. PubMed ID: 14275430
[No Abstract] [Full Text] [Related]
15. [CONSEQUENCES ON GROWTH OF CORTICOTHERAPY FOR 14 YEARS IN A CASE OF STILL'S DISEASE].
LOUYOT P; GAUCHER A; BENOIT P; RABOUILLE D
Ann Med Nancy; 1965 Jan; 4():48-55. PubMed ID: 14280183
[No Abstract] [Full Text] [Related]
16. POLYMYOSITIS AND OTHER DISEASES RESEMBLING MUSCULAR DYSTROPHY.
DOWBEN RM; VAWTER GF; BRANDFONBRENNER A; SNIDERMAN P; KAEGY RD
Arch Intern Med; 1965 May; 115():584-94. PubMed ID: 14278728
[No Abstract] [Full Text] [Related]
17. [THE RISK OF PROLONGED THERAPY WITH CORTISONE DERIVATIVES IN RHEUMATOLOGY].
ISEMEIN L; REDON M; TABAU R
Poumon Coeur; 1963; 19():1195-203. PubMed ID: 14105656
[No Abstract] [Full Text] [Related]
18. [TREATMENT OF HYPERTHYROIDISM].
KLEIN E
Dtsch Med Wochenschr; 1965 May; 90():924-7. PubMed ID: 14278085
[No Abstract] [Full Text] [Related]
19. THYROID EYE-SIGNS IN NEPHROTIC SYNDROME: A SIDE-EFFECT OF STEROID THERAPY?
OPIE WH; OPIE LH
S Afr Med J; 1965 Jul; 39():577-9. PubMed ID: 14338514
[No Abstract] [Full Text] [Related]
20. THE ESTIMATION OF MEAN POTENTIAL DURATION IN ENDOCRINE MYOPATHY.
YATES DA
J Neurol Neurosurg Psychiatry; 1963 Oct; 26(5):458-61. PubMed ID: 14066639
[No Abstract] [Full Text] [Related]
[Next] [New Search]
